Day: January 28, 2025

Nokia CorporationStock Exchange Release28 January 2025 at 22:30 EET Nokia Corporation: Repurchase of own shares on 28.01.2025 Espoo, Finland – On 28 January 2025 Nokia Corporation (LEI: 549300A0JPRWG1KI7U06) has acquired its own shares (ISIN FI0009000681) as follows:Trading venue (MIC Code) Number of shares Weighted average price / share, EUR*XHEL 872,093 4.32CEUX – –BATE – –AQEU – –TQEX – –Total 872,093 4.32* Rounded to two decimals On 22 November 2024, Nokia announced that its Board of Directors is initiating a share buyback program to offset the dilutive effect of new Nokia shares issued to the shareholders of Infinera Corporation and certain Infinera Corporation share-based incentives. The repurchases in compliance with the Market Abuse Regulation (EU) 596/2014...

The grant funding will further Tevogen Bio’s mission to develop therapies for treatment of cancers and viral infections. Tevogen Bio may also utilize the grant funding to further expand its artificial intelligence effort. This grant is in addition to the previously announced $36 million loan agreement from 2Q24.WARREN, N.J., Jan. 28, 2025 (GLOBE NEWSWIRE) — Tevogen Bio (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech, announced it may receive up to $10 million of non-dilutive grant funding. Tevogen Bio signed a grant agreement with KRHP LLC, receiving an initial contribution of $2 million. An additional $8 million may be contributed at a future date, contingent on KRHP LLC’s review of the Company’s activities. The grant is intended to further Tevogen Bio’s mission to...

RYE, N.Y., Jan. 28, 2025 (GLOBE NEWSWIRE) — David Schachter, Senior Vice President of GAMCO Investors, Inc., will visit the United Kingdom to convey support for the British investment trust industry. With over 40 years of experience exclusively with retail, long term, closed-end fund investors, Mr. Schachter, a most senior and experienced veteran of the U.S. Closed End Fund industry, was recently given the title of Discount Doctor by the Trustees of The GAMCO Natural Resources, Gold & Income Trust (GNT), which trades on the NYSE. Mr. Schachter said, “The way I see it, the United States owes a debt to the British Investment Trust Industry, which helped build our railroads in the 1800s. Last week in his inauguration speech, President Trump spoke of America’s achievements stating, ‘In America, the impossible is what we do best…Together...

NEW YORK, Jan. 28, 2025 (GLOBE NEWSWIRE) — SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS” or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a broad range of cancer indications, today announced that it has entered into a securities purchase agreement with a single healthcare-focused institutional investor for the purchase and sale of 19,685,040 shares of its common stock (or common stock equivalents in lieu thereof) and warrants to purchase up to an aggregate of 19,685,040 shares of common stock in a registered direct offering (the “Offering”) at a combined purchase price of $1.27 per share and accompanying warrant, priced at-the-market under Nasdaq rules. The warrants will have an exercise price of $1.20 per share, will be immediately exercisable...

BROSSARD, Quebec, Jan. 28, 2025 (GLOBE NEWSWIRE) — Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a pioneer in early detection of critical health issues through the use of its FLAIRE platform based on Artificial Intelligence (AI), is pleased to announce its participation in The Microcap Conference 2025, the premier event for growth-focused companies and investors. The conference will take place January 28-30, 2025, at the Borgata Hotel Spa & Casino in Atlantic City, NJ. Details of the presentation:Event: The Microcap ConferenceDate and Time: January 29, 2025, at 4:30 p.m., ETLocation: Borgata Hotel Casino & Spa, Studio C, Atlantic City, NJPresenter: André Larente, Chief Executive OfficerDIAGNOS will engage in one-on-one meetings with institutional and individual...

TOANO, Va., Jan. 28, 2025 (GLOBE NEWSWIRE) — C&F Financial Corporation (the Corporation) (NASDAQ: CFFI), the holding company for C&F Bank, today reported consolidated net income of $6.0 million for the fourth quarter of 2024, compared to $5.1 million for the fourth quarter of 2023. The Corporation reported consolidated net income of $19.9 million for the year ended December 31, 2024, compared to $23.7 million for the year ended December 31, 2023. The following table presents selected financial performance highlights for the periods indicated:                                   For The Quarter Ended   For the Year Ended  Consolidated Financial Highlights (unaudited)   12/31/2024     12/31/2023   12/31/2024     12/31/2023  Consolidated net income (000’s)   $ 6,029     $ 5,088   $ 19,918     $ 23,746                                 Earnings...

An extraordinary general meeting in Kaldvik AS (the “Company”) was held today, 28 January 2025, at 12:00 hours (CET) with approximately 87.42% of all shares entitled to vote present either in person or by proxy. The extraordinary general meeting resolved to elect Renate Larsen as new board member in the Company. A copy of the minutes is attached to this announcement. This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading ActAttachmentKaldvik AS EGM minutes

Press release – Paris, January 28th, 2025 Group founders enter into a programmed trading mandateIntention to reinvest in the Company through share buyback Following the conversion of their class G preferred shares1 into ordinary shares, Mrs Evelyne Chétrite, Mrs Judith Milgrom and Mr Ilan Chétrite, Deputy General Managers (Directeurs Généraux Délégués) of SMCP (the “Founders”), have entrusted today an investment services provider, acting independently, with a programmed trading mandate (mandat de gestion programmée) until December 31st, 2025, to sell, as a consequence of the applicable tax regime, and as from March 3rd, 2025, up to 1,872,539 ordinary shares2 resulting from this conversion, on the market or over-the-counter. The Founders reaffirm their commitment and confidence in the Company and intend to reinvest a significant...